| Centers | ||
| Drug Discovery Unit | Saint Louis University Institute for Drug and Biotherapeutic Innovation (IDBI) | EU-OPENSCREEN | 
| The Drug Discovery Unit (DDU) is a fully integrated drug discovery group established to translate world-class biology research into novel drug targets and candidate drugs. Housed within purpose built facilities at the University of Dundee, the  DDU...Read more | 
 The IDBI is a decentralized, collaborative institute whose mission is to promote the translation of research projects at Saint Louis University through drug discovery and pre-clinical development. The IDBI achieves this through four main... | EU-OPENSCREEN is a multinational, not-for-profit initiative, which 
integrates high-capacity screening platforms and chemistry groups across
 Europe. The aim of this initiative is to support individual scientists 
interested in chemical  biology... | 
| Partnerships | Events | Jobs | 
| Sanofi to Collaborate with UCSF to Develop New Drugs to Treat DiabetesUniversity of California, San Francisco (UCSF) has entered into a broad collaboration agreement with Sanofi to develop new therapies to treat Diabetes (Type 1 & 2). Scientists with deep biology expertise at Sanofi will be partnering with... View all TB Drug Accelerator
 View all Janssen Partners with Evotec-Harvard Diabetes Collaboration ProgramJanssen Pharmaceutical a division of Johnson & Johnson has entered into partnership with Harvard University - Evotec's Diabetes program called CureBeta. Janssen will paying $300million in milestone payments per product in addition to $8million in... View all | No EVENTS for listing | No Job Posts | 



 
								 
								 
								 
						 		
								 
								
								 
								
								 
								
								 
								
								 
								
								 
								
								